George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,913.00
Bid: 1,916.00
Ask: 1,918.00
Change: 59.00 (3.18%)
Spread: 2.00 (0.104%)
Open: 1,861.00
High: 1,920.00
Low: 1,861.00
Prev. Close: 1,854.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

11 Mar 2014 09:03

Tuesday broker round-up UPDATE

Aviva: RBC Capital takes target price from 400p to 550p upgrading to neutral. Nomura increases target price from 489p to 625p and reiterates a buy recommendation. Balfour Beatty: Citi raises target price from 220p to 310p maintaining a neutral rating. Goldman Sachs reduces target price from 335p to

Read more
11 Mar 2014 06:39

UK Earnings, Trading Statements Calendar - Week Ahead

Tuesday, March 11 
ComputacenterRead more
10 Mar 2014 15:12

UK Earnings, Trading Statements Calendar - Week Ahead

Tuesday, March 11 
ComputacenterRead more
10 Mar 2014 06:34

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
7 Mar 2014 14:55

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
5 Mar 2014 15:44

UK Earnings, Trading Statements Calendar - Week Ahead

Read more
21 Feb 2014 10:17

UK BROKER RATINGS: JPMorgan Raises View On Home Building Sector

LONDON (Alliance News) - The following UK shares received analyst recommendations Friday morning:
----------
FTSE 100
----------
UBS RAISES VODAFONE PRICE TARGET TO 275 (260) PENCE - 'BUY'
----------
UBS CUTS SMITHS GROUP TO 'SELL' ('NEUTRAL') -

Read more
18 Feb 2014 10:05

UK BROKER RATINGS: Four Brokers Raise Hammerson Price Target

LONDON (Alliance News) - The following UK shares received analyst recommendations Tuesday morning:
----------
FTSE 100
----------
CITIGROUP CUTS ROLLS-ROYCE TO 'NEUTRAL' ('BUY')
----------
BERENBERG CUTS TATE & LYLE PRICE TARGET TO 775 (900)

Read more
14 Feb 2014 14:48

FTSE 250 movers: Kazakhmys extends rise on currency valuation change

Copper miner Kazakhmys surged today, extending gains made earlier this week after the Kazakh government devalued its local currency which investors hope will lead to lower costs for the firm. Shares of Essar Energy are rocketing after the company announced that all main units have resumed operation

Read more
14 Feb 2014 13:06

UK MIDDAY BRIEFING: Lloyds Appoints TSB Chairman Ahead Of London Listing

LONDON (Alliance News) - Lloyds Banking Group has appointed Will Samuel, a former Citi investment banker and adviser to one of the UK financial services regulators, as Chairman of TSB Bank, the bank it split out as a separate entity last year and is expected to list this year.

Read more
14 Feb 2014 11:03

TOP NEWS: Eurozone Economies Grow Faster Than Expected

LONDON (Alliance News) - The following is a summary of top news stories Friday.
----------
COMPANIES
----------
Lloyds Banking Group PLC appointed Will Samuel, a former Citi investment banker and adviser to one of the UK financial services

Read more
14 Feb 2014 10:46

UK WINNERS & LOSERS: Mariana Drops As Field Technician Is Abducted

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Friday.

-------

FTSE 100 - WINNERS

Petrofac, up 2.7%. Petrofac shares have been on a downward trend over the

Read more
14 Feb 2014 10:26

Friday broker round-up UPDATE

Assura Group: Liberum Capital shifts target price from 44p to 44.40p and retains a buy recommendation. Barclays: Credit Suisse lowers target price from 270p to 260p and keeps a neutral rating. Bellway: Panmure Gordon raises target price from 1520p to 1639p and maintains a buy recommendation. UBS i

Read more
14 Feb 2014 10:10

UK BROKER RATINGS: Six Brokers Cut Tate & Lyle Price Target

LONDON (Alliance News) - The following UK shares received analyst recommendations Friday morning:
----------
FTSE 100
----------
JPMORGAN RAISES LLOYDS TO 'OVERWEIGHT' ('NEUTRAL') - TARGET 95 (84) PENCE
----------
SOCGEN RAISES LLOYDS PRICE TARGE

Read more
14 Feb 2014 09:32

UPDATE 1-Drugmaker Hikma estimates 23 percent full-year revenue growth

Feb 14 (Reuters) - Jordan's Hikma Pharmaceuticals Plc said it expects a 23 percent growth in full-year revenue, up from its prior forecast of about 20 percent, benefiting from a strong performance in its injectables and generics businesses towards the end of 2013. The London-listed company

Read more

Quickpicks are a member only feature

Login to your account